HAYDEN BRIAN J 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 19, 2009
Insider Transaction Report
Form 4
HAYDEN BRIAN J
SVP, Chief Financial Officer
Transactions
- Sale
Common Stopck, $.01 par value per share
2009-02-17$5.77/sh−3,441$19,840→ 11,445 total
Footnotes (1)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 15, 2007.